![PDF) Lupus and the Antiphospholipid Syndrome in Pregnancy and Obstetrics: Clinical Characteristics, Diagnosis, Pathogenesis, and Treatment PDF) Lupus and the Antiphospholipid Syndrome in Pregnancy and Obstetrics: Clinical Characteristics, Diagnosis, Pathogenesis, and Treatment](https://i1.rgstatic.net/publication/23187283_Lupus_and_the_Antiphospholipid_Syndrome_in_Pregnancy_and_Obstetrics_Clinical_Characteristics_Diagnosis_Pathogenesis_and_Treatment/links/09e4150d6e22374234000000/largepreview.png)
PDF) Lupus and the Antiphospholipid Syndrome in Pregnancy and Obstetrics: Clinical Characteristics, Diagnosis, Pathogenesis, and Treatment
![PDF) [Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] PDF) [Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies]](https://i1.rgstatic.net/publication/11285233_Neonatal_lupus_clinical_features_and_risk_of_congenital_cardiac_heart_block_in_newborns_from_mothers_with_anti_RoSSA_antibodies/links/0fcfd50f7a3675007a000000/largepreview.png)
PDF) [Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies]
![PDF) TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects PDF) TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects](https://i1.rgstatic.net/publication/273530515_TNFa_inhibition_in_anti-RoSSA_positive_patients_with_rheumatoid_arthritis_clinical_and_immunological_effects/links/55e57b2308aec74dbe732b79/largepreview.png)